The Shh ligand can also be secreted by tumor cells and can participate in paracrine signaling, activating the Hh/GLI signaling pathway in both tumor and stromal cells, often seen in pancreatic and prostate cancers [34,235,241,242]. The gene discussed is GLI1; the disease is neoplasm.